Evidence map›Paper›PMID 30844236›Full record

ArticleACS nano2019

Weak Multivalent Binding of Influenza Hemagglutinin Nanoparticles at a Sialoglycan-Functionalized Supported Lipid Bilayer.

Daniele Di Iorio, Mark L Verheijden, Erhard van der Vries, Pascal Jonkheijm, Jurriaan Huskens

Abstract read
In one paragraph

Article in ACS nano, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Reciprocity in dynamics of supramolecular biosystems for the clustering of ligands and receptors.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Streptavidin Coverage on Biotinylated Surfaces.ACS applied materials & interfaces · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniele Di IorioMolecular Nanofabrication Group, MESA + Institute for Nanotechnology, Faculty of Science and Technology , University of Twente , P.O. Box 217, 7500 AE Enschede , The Netherlands.
Mark L VerheijdenMolecular Nanofabrication Group, MESA + Institute for Nanotechnology, Faculty of Science and Technology , University of Twente , P.O. Box 217, 7500 AE Enschede , The Netherlands.
Erhard van der VriesVirology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine , Utrecht University , 3584 CL Utrecht , The Netherlands.
Pascal JonkheijmMolecular Nanofabrication Group, MESA + Institute for Nanotechnology, Faculty of Science and Technology , University of Twente , P.O. Box 217, 7500 AE Enschede , The Netherlands.ORCID 0000-0001-6271-0049
Jurriaan HuskensMolecular Nanofabrication Group, MESA + Institute for Nanotechnology, Faculty of Science and Technology , University of Twente , P.O. Box 217, 7500 AE Enschede , The Netherlands.ORCID 0000-0002-4596-9179

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantification of the multivalent interactions of influenza viruses binding at interfaces may provide ways to tackle key biological questions regarding influenza virulence and zoonoses. Yet, the deconvolution of the contributions of molecular and interfacial parameters, such as valency, interaction area, and receptor density, to the binding of whole viruses is hindered by difficulties in the direct determination of these parameters. We report here a chemical platform technology to study the binding of multivalent recombinant hemagglutinin (rHA) nanoparticles at artificial sialoglycan cell receptor-presenting interfaces in which all these parameters can be derived, thus allowing the desired full and quantitative binding analysis. SiO

Indexed as

Binding SitesHemagglutinin Glycoproteins, Influenza VirusHumansLipid BilayersNanoparticlesOrthomyxoviridaeRecombinant ProteinsHemagglutinin Glycoproteins, Influenza VirusLipid BilayersRecombinant Proteinscell mimicsglycanshemagglutinininfluenza virusinterfacemultivalency

Identifiers

PMID30844236
PMCPMC6439437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.